Key facts
- This page summarizes Jonathan E. Lim's Form 4 filing for Boundless Bio, Inc. (BOLD).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 20 Jun 2024, 19:49.
Jonathan E. Lim - 20 Jun 2024 Form 4 Insider Report for Boundless Bio, Inc. (BOLD)
- Role
- Director
- Signature
- /s/ Jessica Oien, Attorney-in-Fact for Jonathan Lim
- Issuer symbol
- BOLD
- Transactions as of
- 20 Jun 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 20 Jun 2024, 19:49:55 UTC
- Previous filing
- 04 Apr 2024
- Next filing
- 30 Jan 2025
- SEC
- View on sec.gov
Key filing fact
Jonathan E. Lim filed Form 4 for Boundless Bio, Inc. (BOLD) on 20 Jun 2024.
Change
- Previous filing in this sequence was filed on 04 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
BOLD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +6,610
- Change %
- Price
- $0.000000
- Shares after
- 6,610
- Date
- 20 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,610
- Exercise price
- $5.50
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The option was granted pursuant to the Issuer's 2024 Incentive Award Plan. The stock option vests in 36 substantially equal monthly installments beginning on the first monthly anniversary of June 20, 2024, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. |